The view that SIRT1 stimulates the survival of cancer cells is additionally supported by the fact that a greater expression of SIRT1 results in higher chemoresistance and lower efficacy of chemotherapy in lung cancer cell line H292 [76]. Here, SIRT1 is linked to lung carcinoma.